| Krystal E Hudgens, AUD, CCC-A | |
|
11500 N Portland Ave, Oklahoma City, OK 73120-4625 | |
| (405) 548-4300 | |
| (405) 548-4350 |
| Full Name | Krystal E Hudgens |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 12 Years |
| Location | 11500 N Portland Ave, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255699849 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hearts For Hearing Foundation | 8820195399 | 30 |
News Archive
A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare but potentially actionable driver for non-small cell lung cancer (NSCLC).
Oncotarget published "Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia" which reported that the standard treatment for pediatric AML currently consists in a combination of cytarabine and antracycline.
Genetics Squared, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, today announced that it will change its corporate name to Everist Genomics and has appointed Prasad Sunkara, Ph.D. as its new President and Chief Executive Officer, effective immediately.
ReShape Medical® Inc announced today that it has completed enrollment in the pivotal clinical trial for the ReShape Duo® Intragastric Balloon, one of the first non-surgical weight loss devices developed for the U.S. market.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
› Verified 6 days ago
| Provider Name | Hearts For Hearing Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215006150 PECOS PAC ID: 8820195399 Enrollment ID: O20070517000246 |
News Archive
A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare but potentially actionable driver for non-small cell lung cancer (NSCLC).
Oncotarget published "Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia" which reported that the standard treatment for pediatric AML currently consists in a combination of cytarabine and antracycline.
Genetics Squared, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, today announced that it will change its corporate name to Everist Genomics and has appointed Prasad Sunkara, Ph.D. as its new President and Chief Executive Officer, effective immediately.
ReShape Medical® Inc announced today that it has completed enrollment in the pivotal clinical trial for the ReShape Duo® Intragastric Balloon, one of the first non-surgical weight loss devices developed for the U.S. market.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Krystal E Hudgens, AUD, CCC-A 11500 N Portland Ave, Oklahoma City, OK 73120-4625 Ph: (405) 548-4300 | Krystal E Hudgens, AUD, CCC-A 11500 N Portland Ave, Oklahoma City, OK 73120-4625 Ph: (405) 548-4300 |
News Archive
A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare but potentially actionable driver for non-small cell lung cancer (NSCLC).
Oncotarget published "Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia" which reported that the standard treatment for pediatric AML currently consists in a combination of cytarabine and antracycline.
Genetics Squared, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, today announced that it will change its corporate name to Everist Genomics and has appointed Prasad Sunkara, Ph.D. as its new President and Chief Executive Officer, effective immediately.
ReShape Medical® Inc announced today that it has completed enrollment in the pivotal clinical trial for the ReShape Duo® Intragastric Balloon, one of the first non-surgical weight loss devices developed for the U.S. market.
Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs-which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide-stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
› Verified 6 days ago
Mrs. Farris Ree Stroupe, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4140 W. Memorial Rd Suite 116, Oklahoma City, OK 73120 Phone: 405-755-1930 | |
Kristen Macdougall Bybee, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1200 Childrens Ave # 8c, Oklahoma City, OK 73104 Phone: 405-271-2662 | |
Kerri Anne Conley, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3400 Nw 56th St, Oklahoma City, OK 73112 Phone: 405-949-1906 | |
Dr. Elizabeth Ann Harder, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 535 Nw 9th St, Suite 305, Oklahoma City, OK 73102 Phone: 405-272-6027 | |
Ms. Esther H Kim, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 11500 N Portland Ave, Oklahoma City, OK 73120 Phone: 405-548-4300 Fax: 405-548-4349 | |
Dr. Elizabeth Ruth Elliott, AU.D., M.B.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-270-0501 Fax: 405-552-4365 | |
Jace A Wolfe, PHD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 11500 N Portland Ave, Oklahoma City, OK 73120 Phone: 405-548-4300 |